Praveen Tyle Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

LXRX Quotes by TradingView

Praveen Tyle is EVP, R&D of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 120,791 shares of LXRX, which is worth approximately $85,761. The most recent transaction as insider was on Feb 28, 2021, when has been sold 16,560 shares (Common Stock) at a price of $7.19 per share, resulting in proceeds of $119,066. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K
0% 3M change
0% 12M change
Total Value Held $85,761

PRAVEEN TYLE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2021
SELL
Payment of exercise price or tax liability
$119,066 $7.19 p/Share
16,560 Reduced 12.06%
120,791 Common Stock
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
68,007 Added 33.12%
137,351 Common Stock

Also insider at

KPRX
KIORA PHARMACEUTICALS INC Healthcare
Director
SKYE
Skye Bioscience, Inc. Healthcare
Director
PT

Praveen Tyle

EVP, R&D
Waltham, MA

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LXRX